About:
AGAMREE is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
www.agamree.com | www.yourcatalystpathways.com | Prescribing Information | Enrollment Form
We're with you
every day
Our Patients Are Our First Priority
At Anovo (AnovoRx), we've built our unique care management model to ensure that you have constant and consistent access to the therapies you need and experts to help guide you through your therapeutic journey.
Meet some of our patients and hear their stories about how we help.
Compassion Powered by Expertise
At Anovo (AnovoRx), we understand that living with a rare disease or managing care for someone you love is about more than taking medication. It’s about trust, timeliness, and feeling supported every single step of the way. That’s why our approach marries high-touch care with fully integrated systems—you’re never just a patient number.
Our Care Coordinators and registered nurse case managers partner closely with you and your loved ones to:
Answer questions and provide guidance the moment you need it
Simplify insurance access and reduce financial stress
Ensure therapy starts quickly—and stays on track
Help you never miss a dose through personalized follow-up plans
One Partner, One Promise
Care shouldn’t shift between different systems. With Anovo:
- Your case moves seamlessly from insurance approval to pharmacy shipment
- Every team—from benefits specialists to distribution experts—is aligned on your care plan
- Our secure systems give your healthcare provider a complete, real-time snapshot of your therapy progress
- When you call us, every department is already connected—no repeating details, no long hold times.
When you call us, every department is already connected—no repeating details, no long hold times.
Speed, Accuracy, and Peace of Mind
Rare therapies often come with challenges like prior authorizations, appeal processes, and special storage needs. Our specialized team:
- Verifies benefits and pharmacy coverage from day one
- Manages appeals and patient assistance support
- Coordinates cold-chain shipping and timely delivery
- Monitors refill schedules and adherence with proactive check-ins
Our goal? A care experience that feels effortless and reliable—so you can focus on what truly matters.
Patient-First Delivered Differently
What makes Anovo unique:
- Deep rare disease experience: Your therapy is distinct—and so is our approach
- One unified support path: No handoffs. No miss-outs. Just one dedicated partner
- Streamlined visibility: Whether you’re a patient, caregiver, or provider—you see the full picture
- Customized care plans: From starter kits to dosage support—we adapt to your individual needs
A White-Glove Experience That Stays With You
- A single care team, there from day one
- Personalized touchpoints, designed around your life
- Proactive support through every refill, dose change, or question
We’re more than a pharmacy. We’re the ally that ensures your therapy doesn’t just reach you—it reaches you well-supported, every time.
Patient Resources
Patient Frequently Asked Questions
Notice of Nondiscrimination
Notice of Availability of Language Assistance
Grievance Procedures
Modification Notice
Effective Communications Notice
Notice of Privacy Practices
Product Resources
About:
ALKINDI SPRINKLE is a corticosteroid indicated as replacement therapy in pediatric patients with adrenocortical insufficiency.
www.alkindisprinkle.com | Prescribing Information | Referral Form
About:
ANASCORP is an antivenom indicated for treatment of clinical signs of scorpion envenomation.
About:
Betaine Anhydrous for Oral Solution is a methylating agent indicated in pediatric and adult patients for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations.
About:
Carglumic Acid tablets for oral suspension are indicated in pediatric and adult patients as adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to NAGS deficiency; and maintenance therapy for the treatment of chronic hyperammonemia due to NAGS deficiency.
www.carglumicacid.com | Prescribing Information | Referral Form
About:
CYSTADANE is a methylating agent indicated in pediatric and adult patients for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations.
www.cystadane.com | Prescribing Information | Prescription Order Form
About:
CYSTADROPS is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis.
www.cystadrops.com | Prescribing Information | Prescription Order Form
About:
DAYBUE is indicated for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older.
www.daybue.com | www.acadiaconnect.com | Prescribing Information | Prescription and Enrollment Form
About:
FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older.
www.fintepla.com | www.fintepla.com/onward-support/ | Prescribing Information | REMS Prescriber Enrollment Form | Prescription Authorization and Patient Referral Form
About:
FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older.
www.firdapse.com | www.yourcatalystpathways.com | Prescribing Information | Enrollment Form
About:
FORZINITY is a mitochondrial cardiolipin binder indicated to improved muscle strength in adult and pediatric patients with Barth syndrome weighing at least 30 kg.
About:
Galzin is indicated for maintenance treatment of patients with Wilson’s disease who have been initially treated with a chelating agent.
About:
INCRELEX injection is indicated for the treatment of growth failure in pediatric patients 2 years of age and older with severe primary IGF-1 deficiency or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to GH.
About:
ISTURISA is a cortisol synthesis inhibitor indicated for the treatment of adult patients with Cushing’s disease for whom pituitary surgery is not an option or has not been curative.
www.isturisa.com | www.rareresources.com | Prescribing Information | Patient Prescription Form
About:
KHINDIVI is an oral solution hydrocortisone indicated as replacement therapy in pediatric patients with congenital adrenal hyperplasia (CAH).
About:
Nitisinone is a hydroxy-phenylpyruvate dioxygenase inhibitor indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.
About:
SIGNIFOR is a somatostatin analog indicated for the treatment of adult patients with Cushing’s disease for whom pituitary surgery is not an option or has not been curative.
www.signifor.com | www.rareresources.com | Prescribing Information | Patient Prescription Form |
About:
SIGNIFOR LAR is a somatostatin analog indicated for the treatment of patients with acromegaly who have had an inadequate response to surgery and/ or for whom surgery is not an option; and for the treatment of patients with Cushing’s disease for whom pituitary surgery is not an option or has not been curative.
www.signiforlar.com | www.rareresources.com | Prescribing Information | Patient Prescription Form
About:
TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS).